BioMarin Pharmaceutical, Inc. (BMRN)
58.51
-0.56
(-0.95%)
USD |
NASDAQ |
Mar 13, 16:00
58.51
0.00 (0.00%)
After-Hours: 20:00
BioMarin Pharmaceutical Shareholders Equity (Quarterly) : 6.087B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 274.24M |
| Gilead Sciences, Inc. | 22.70B |
| Merck & Co., Inc. | 52.61B |
| MannKind Corp. | -51.02M |
| AbbVie, Inc. | -3.27B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.594B |
| Total Liabilities (Quarterly) | 1.507B |
| Debt to Equity Ratio | 0.1056 |
| Current Ratio | 5.179 |
| Net Debt Paydown Yield | -0.06% |